###begin article-title 0
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
###xml 84 89 <span type="species:ncbi:9606">Human</span>
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
###end article-title 0
###begin p 1
Conceived and designed the experiments: EO HI PT. Performed the experiments: EO HI JG SP PM LM AP ZM JL TI SI DM LT. Analyzed the data: EO HI JG TI. Contributed reagents/materials/analysis tools: GU AB EO HI JG EG BA BH TI TA. Wrote the paper: EO HI.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 324 327 <span type="species:ncbi:10116">rat</span>
Addiction and major depression are mental health problems associated with stressful events in life with high relapse and reoccurrence even after treatment. Many laboratories were not able to detect the presence of cannabinoid CB2 receptors (CB2-Rs) in healthy brains, but there has been demonstration of CB2-R expression in rat microglial cells and other brain associated cells during inflammation. Therefore, neuronal expression of CB2-Rs had been ambiguous and controversial and its role in depression and substance abuse is unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">Mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 868 873 <span type="species:ncbi:10090">mouse</span>
###xml 888 893 <span type="species:ncbi:10090">mouse</span>
In this study we tested the hypothesis that genetic variants of CB2 gene might be associated with depression in a human population and that alteration in CB2 gene expression may be involved in the effects of abused substances including opiates, cocaine and ethanol in rodents. Here we demonstrate that a high incidence of (Q63R) but not (H316Y) polymorphism in the CB2 gene was found in Japanese depressed subjects. CB2-Rs and their gene transcripts are expressed in the brains of naive mice and are modulated following exposure to stressors and administration of abused drugs. Mice that developed alcohol preference had reduced CB2 gene expression and chronic treatment with JWH015 a putative CB2-R agonist, enhanced alcohol consumption in stressed but not in control mice. The direct intracerebroventricular microinjection of CB2 anti-sense oligonucleotide into the mouse brain reduced mouse aversions in the plus-maze test, indicating the functional presence of CB2-Rs in the brain that modifies behavior. We report for the using electron microscopy the sub cellular localization of CB2-Rs that are mainly on post-synaptic elements in rodent brain.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our data demonstrate the functional expression of CB2-Rs in brain that may provide novel targets for the effects of cannabinoids in depression and substance abuse disorders beyond neuro-immunocannabinoid activity.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Degenhardt1">[1]</xref>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Willner1">[2]</xref>
###xml 456 459 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Volkow1">[3]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Manzanares1">[4]</xref>
###xml 561 564 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Vinod1">[5]</xref>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Degenhardt1">[1]</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Manzanares1">[4]</xref>
###xml 943 946 943 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Bovasso1">[6]</xref>
###xml 948 951 948 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Patton1">[7]</xref>
###xml 1025 1028 1025 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi1">[8]</xref>
###xml 1112 1115 1112 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Manzanares1">[4]</xref>
###xml 1202 1205 1202 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Vinod1">[5]</xref>
###xml 1268 1271 1268 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi1">[8]</xref>
###xml 1630 1633 1630 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Munro1">[9]</xref>
###xml 1634 1638 1634 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Griffin1">[11]</xref>
###xml 1766 1770 1766 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Benito1">[12]</xref>
###xml 1771 1775 1771 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Sheng1">[17]</xref>
###xml 1938 1942 1938 1942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi2">[18]</xref>
###xml 2059 2063 2059 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ishiguro1">[19]</xref>
###xml 619 628 <span type="species:ncbi:3483">marijuana</span>
###xml 1254 1263 <span type="species:ncbi:3483">marijuana</span>
###xml 1692 1695 <span type="species:ncbi:10116">rat</span>
###xml 2029 2033 <span type="species:ncbi:10090">mice</span>
###xml 2052 2058 <span type="species:ncbi:9606">humans</span>
Drug addiction and major depression are mental health problems associated with stressful events in life with high relapse and reoccurrence even after treatment [1]. Major depression is characterized by mood changes and anhedonia. Anhedonia is a lack of interest in pleasurable things of life and can be studied using the chronic mild stress (CMS) model of depression in rodents [2]. Like depression, it is recognized that drug addiction is a brain disease [3]. Significant effort has been made to uncover genetic markers for substance abuse and depression [4], [5]. One rationale for use of abused substances including marijuana is the self-medication hypothesis. Evidence for an association between cannabis use and depression has grown [1]. Comorbid presentation of cannabis abuse and depression is common [4]. Studies suggest that cannabis abuse in adults increases depressive symptoms, but depression does not predict later cannabis abuse [6], [7]. The discovery of an endocannabinoid physiological control system (EPCS) [8], has led to the examination of this system in CNS and its role in mental disorders [4]. Thus a role of the EPCS in a number of neuropsychiatric disorders has been described [5]. Two receptors are activated by cannabinoids or marijuana use [8]. CB1-Rs are expressed in brain and periphery, while CB2-Rs were thought to be expressed in immune cells and were referred to as peripheral CB2-Rs. However, the neuronal expression of CB2-Rs in the brain and its role in depression and substance abuse is unknown. While a number of laboratories were not able to detect the presence of CB2-Rs in healthy brains [9]-[11], there has been demonstration of CB2-R expression in rat microglial cells and other brain associated cells during inflammation [12]-[17]. Preliminary report of some of the data have been presented as abstracts at scientific conferences and described in summary form in a recent general review paper [18]. We have also reported the involvement of cannabinoid CB2-Rs in alcohol preference in mice and alcoholism in humans [19], which supports the functional presence of neuronal CB2-Rs in the mammalian CNS.
###end p 9
###begin p 10
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi3">[20]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi3">[20]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
With novel and precise cannabinoid probes, our results indicate the expression of brain CB2-Rs in mouse model of depression and in the effects of abused substances [20]. We and others have now identified and reported the presence of CB2-Rs in brain neuronal and glial process [20]-[24]. To further improve understanding of the role of CB2-Rs in the brain, we hypothesized that genetic variants of CB2 gene might be associated with depression in a human population and that alteration in CB2 gene expression may be involved in the effects of abused substances in rodents. Our data reveals that CB2-Rs are expressed in brain and plays a role in depression and substance abuse.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
Involvement of CB2 gene expression in depression and in the effects of abused drugs
###end title 12
###begin p 13
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ashton1">[22]</xref>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g001">Fig. 1A</xref>
###xml 307 310 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 423 430 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g001">Fig. 1B</xref>
###xml 441 450 441 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g001">figures 1</xref>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
We first determined CB2 gene expression in mice brains exposed to chronic mild stressors or those treated chronically with abused substances like heroin, cocaine, or those on the alcohol consumption preference test [22]. CB2 gene was expressed in whole brain preparations of CMS and control mice (Fig. 1A). CB2 gene expression was then confirmed in different mouse brain areas including striatum, midbrain and hippocampus (Fig. 1B). In both figures 1 A and B, the control samples were set at 1.0 and the spleen was used as positive controls because it has the most abundant expression of CB2-Rs in mammals. These results showed that CB2 gene is present and expressed in the brains of naive mice and in those exposed to chronic mild stress.
###end p 13
###begin title 14
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
Presence of CB2 gene in the brain.
###end title 14
###begin p 15
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 195 200 <span type="species:ncbi:10090">Mouse</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
A, Relative brain expression of CB2 gene in C57BL/6J and BALBc strains subjected to stress. B, Relative CB2 gene expression levels in the striatum, midbrain, and hippocampus of C57Bl/6J mice. C, Mouse whole brain relative CB2 gene expression levels following chronic treatment with heroin and cocaine. D, relative CB2 gene expression levels in striatum and midbrain of mice that developed alcohol preference. CB2 gene expression was relative to the standard laboratory brain obtained from C57BL/6J that was set to 1.0. The positive control was from the spleen and no cDNA in TaqMan PCR reaction served as negative controls.
###end p 15
###begin p 16
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 372 379 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g001">Fig. 1C</xref>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 713 720 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g001">Fig. 1D</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ishiguro1">[19]</xref>
###xml 1188 1195 1188 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-situ</italic>
###xml 1225 1228 1225 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1382 1389 1382 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g002">Fig. 2C</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
We then determined more precisely the involvement of CB2 gene expression in separate groups of mice chronically treated with heroin (10 mg/kg) or cocaine (40 mg/kg) or those exposed to varying alcohol consumption. Chronic treatment with heroin increased (p>0.05) while cocaine significantly (p<0.05) increased CB2 gene expression in mouse brain preparations using RT-PCR (Fig. 1C). In mice subjected to the chronic varying alcohol intake paradigm for alcohol preference, there was significant reduction CB2 gene expression in the striatum (P = 0.05) and ventral midbrain (p = 0.04), whereas in mice with little preference for drinking alcohol, there were no changes in CB2 gene expression in these brain regions (Fig. 1D). The alcohol data support our previous studies [19] that CB2-R agonist JWH015 administration enhances alcohol intake in stressed but not in non-stressed control mice. In contrast the administration of the CB2-R antagonist AM630 reduced alcohol intake (P = 0.08) in stressed but had no effect in the alcohol consumption in non-stressed naive mice. The presence of CB2-Rs in the brain was further investigated in CB2-R deficient mice and their wild type litter mates. In-situ hybridization data show that CB2 gene is expressed in the cerebellum of wild type and not in the cerebellum of the CB2-R deficient mice and also in sense controls in the wild type mice (Fig. 2C). Altogether, these results revealed the functional presence of brain CB2-Rs that plays a role in the effects of abused substances.
###end p 16
###begin title 17
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-situ</italic>
Brain CB2-Rs: Immunoblots, genotyping and in-situ hybridization.
###end title 17
###begin p 18
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-situ</italic>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
A, In-situ hybridization indicating CB2 gene is expressed in the cerebellum of wild type and not in the cerebellum of the CB2-R deficient mice and also in sense controls in the wild type mice. B, RFLP genotyping discrimination on agarose gel for CB2 Q63R polymorphism in depressed subjects (Ba) and, Resequences of CB2 Q63R polymorphism (Bb). C, Western blotting of CB2-Rs in CMS and control mice (left panel) and in right panel in mice exposed to 4 mg/kg capsaicin in utero.
###end p 18
###begin p 19
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 407 414 407 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g002">Fig. 2B</xref>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001640-t001">Table 1</xref>
###xml 83 88 <span type="species:ncbi:9606">human</span>
We then examined the association between CB2 gene polymorphism and depression in a human population to test the hypothesis that genetic variants of CB2 gene might be associated with depression and substance abuse in Japanese population. A significant association was found between the CB2 Q63R polymorphism and Japanese depressed subjects (p = 0.007, odds ratio 1.42, 95% confidence interval: 1.09-1.831), (Fig. 2B). Furthermore, because a previous study showed a significant functional difference of RR genotype in lymphocyte, we compared the distribution of subjects without or with Q allele. The RR genotype was significantly associated with depression [p = 0.01, odds ratio 1.95; 95% confidence interval, (1.11-3.4402.28)], (Table 1).
###end p 19
###begin title 20
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2 gene</italic>
Allelic and genotype distribution of R63Q polymorphism in the CB2 gene.
###end title 20
###begin p 21
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Comparisons were made between patients with major depression and the healthy controls. Significant differences are observed in allelic frequency and genotype distribution in the R recessive model. OR is odd ratio.
###end p 21
###begin title 22
Analysis of CB2-Rs in the rodent brain with or without exposure to stressors
###end title 22
###begin p 23
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-situ</italic>
###xml 247 254 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-situ</italic>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g002">Fig. 2A</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-VanSickle1">[21]</xref>
###xml 610 618 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2 gene</italic>
###xml 750 757 750 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g002">Fig. 2A</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 1132 1145 1132 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g003">Fig. 3A and B</xref>
###xml 1411 1413 1407 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1538 1542 1534 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 892 895 <span type="species:ncbi:10116">rat</span>
###xml 1532 1537 <span type="species:ncbi:10090">mouse</span>
To determine the localization of CB2-Rs in mouse and rat brains, we used a combination of Western blotting, immunohistochemistry and in-situ hybridization. The CB2-R knockout mice and their wild type litter mates were included as controls for the in-situ hybridization. We then analyzed CB2-Rs in the brains of mice subjected to chronic mild stressors, including adult mice that had been prenatally exposed to capsaicin. Western blotting analyses from mice brains revealed a major CB2-R band of approximately 53 kDa (Fig. 2A), with other visible bands around 37 kDa and 75 kDa, similar to those reported [21]. CB2 gene was expressed in mouse whole brain preparations and the CB2-R protein was also present in the CMS and prenatal capsaicin exposure (Fig. 2A). The specificity of three commercial CB2-R antibodies had been examined in our previous studies to map CB2-R immunoreactivity in the rat brain [24]. In this study the specificity of the CB2-R antibody used was further confirmed as the CB2-R immunoreactivity detected in the cerebellum were undetectable when the CB2-R antibody was pre-adsorbed with the immunizing peptide (Fig. 3A and B) using 8.3 microg/ml of the CB2 sequence peptide used to produce the antiserum. It is important to note that we previously demonstrated and reported that CB2-R immunoreactivity was present in the CA2 region of the hippocampus, spleen and interpolar part of spinal 5th nucleus of wild type brain and the CB2-R immunoreactivity was absent in these structures in the global CB2-R knockout mouse [24].
###end p 23
###begin title 24
Brain CB2-Rs: Immunoractivity (IR) and pre-adsorption with immunizing peptide.
###end title 24
###begin p 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
A, CB2-IR in the left panel and lack of CB2-IR in the right panel, B, when the CB2 antibody was pre-adsorped with the peptide.
###end p 25
###begin p 26
###xml 90 96 90 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4</xref>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4A</xref>
###xml 375 382 375 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4B</xref>
###xml 436 443 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4C</xref>
###xml 614 621 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4D</xref>
###xml 696 703 696 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g004">Fig. 4D</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-VanSickle1">[21]</xref>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
###xml 156 159 <span type="species:ncbi:10116">rat</span>
###xml 252 255 <span type="species:ncbi:10116">rat</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 415 418 <span type="species:ncbi:10116">rat</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1013 1016 <span type="species:ncbi:10116">rat</span>
We then performed immunohistochemical analysis in the naive mouse and rat brain sections (Fig. 4). Apical dendrites and cell bodies of pyramidal neurons of rat cerebral cortex were moderately to heavily immunolabeled for CB2-R. Scattered fibers in the rat cerebral cortex showed CB2-R-IR (Fig. 4A). CB2-R immunoreactivity (IR) was also observed in the mouse cerebral cortex (Fig. 4B). CB2-R-IR was also observed in rat corpus callosum (Fig. 4C). A moderate to dense CB2 immunostaing was observed in pyramidal neuron of mouse hippocampal allocortex and some interneurons in the stratum oriens and stratum radiatum (Fig. 4D). Some glial cells were also immunolabeled for CB2-Rs in the hippocampus (Fig. 4D). This localization pattern is in agreement with the perfect overlay when double labeling of CB2-Rs and neuron specific enolase (NSE) in hippocampal neuronal cultures was visualized by confocal immunofluorescence imaging [24]. Thus, in the brain areas analyzed CB2-R immunoreactivity was detected in mice and rat brains, and this is supported by reports of identification of neuronal CB2-Rs in the brain stem involved in emesis [21].
###end p 26
###begin title 27
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Brain CB2-Rs: Immunohistochemistry in mouse and rat brain.
###end title 27
###begin p 28
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 140 143 <span type="species:ncbi:10116">rat</span>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
A, CB2-IR in apical dendrites and cell bodies of pyramidal neurons of rat cerebral cortex. B, CB2-IR in mouse cerebral cortex. C, CB2-IR in rat corpus callosum and D, CB2-IR in mouse hippocampal allocortex and some interneurons in the striatum oriens and stratum radiatum.
###end p 28
###begin title 29
Behavioral effects of CB2-R activation and blockade
###end title 29
###begin p 30
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi2">[18]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 514 521 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g005">Fig. 5A</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Valenzano1">[25]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi2">[18]</xref>
###xml 1215 1222 1215 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g005">Fig. 5B</xref>
###xml 1796 1803 1796 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g005">Fig. 5C</xref>
###xml 2197 2204 2197 2204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g005">Fig. 5D</xref>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 499 504 <span type="species:ncbi:10090">mouse</span>
###xml 866 871 <span type="species:ncbi:10090">mouse</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
###xml 1066 1071 <span type="species:ncbi:10090">mouse</span>
###xml 1790 1794 <span type="species:ncbi:10090">mice</span>
###xml 2062 2066 <span type="species:ncbi:10090">mice</span>
###xml 2141 2145 <span type="species:ncbi:10090">mice</span>
If there are functional CB2-Rs in neurons in the brain as new reports demonstrates [18]-[24], then activation and blockade of CB2-Rs may influence behavior. We therefore examined the behavioral effects of acute activation and blockade of CB2-Rs using measures of locomotor activity, time spent in the two- compartment black and white box and in food consumption tests in mice. JWH015 (1-20 mg/kg) a CB2-R agonist, altered mouse locomotor activities in a strain and gender dependent fashion in three mouse strains (Fig. 5A, a-f). Increasing doses of JWH015 in this study reduced the activity of the animals in general, similar to the report [25] with another CB2-R agonist, GW405833. We also previously reported a similar profile of decreased motor function as demonstrated by the reduction in stereotypy following the administration of the JWH015 compound the three mouse strains [18]. This is in support of the strain and gender depression of motor function with the female sensitive than the male mice. The next sets of experiments were then performed in selected mouse strains. In the two- compartment black and white test box, acute treatment with JWH015 (1-20 mg/kg) induced an anxiogenic profile of response (Fig. 5B), with the females of the C57BL/6 strain more sensitive to the aversive behavior in the white chamber. This response was characterized by a decrease in time spent in the white chamber and a concomitant increase in time spent in the black chamber (p<0.05). Acute administration of SR144528 (1-20 mg/kg), a CB2-R antagonist enhanced (P<0.05) the locomotor activity and stereotype behavior in the DBA/2 strain in comparison to vehicle treated controls. The males were more susceptible to locomotor activation by the acute treatment with CB2-R antagonist than the female mice (Fig. 5C). In contrast to the effects of the agonist JWH015, acute treatment with the antagonist SR144528 (1-20 mg/kg) had little or no effect on the time the DBA/2 strain spent in both chambers of the two- compartment black and white box by both the male and female mice except a reduced time (p<0.05) spent in the white compartment by the male mice at the highest dose (20 mg/kg) used in this study (Fig. 5D). The influence of CB2-R ligands on food consumption was also investigated. The enhancement and suppressant effects of CB2-R ligands were strain and time dependent (data are not shown). Thus, there was a clear strain and gender dependent effects following CB2-R activation or inhibition on behavioral responses as measured by locomotor activity, emotionality and food consumption tests.
###end p 30
###begin title 31
Behavioral effects of CB2-R activation and blockade.
###end title 31
###begin p 32
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 3 8 <span type="species:ncbi:10090">Mouse</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
A, Mouse spontaneous locomotor activity following acute treatment with CB2 agonist JWH015 (1-20 mg/kg), in mouse strain, C57Bl/6 (a and b); BALBc, (c and d) and DBA/2 (e and f). B, Effect of JWH015 in C57Bl/6 mice in the two compartment black and white box, showing time spent in the black and white chamber. C, Acute effects of SR144528 - a CB2-R antagonist on DBA/2 mouse spontaneous locomotor activity and stereotype behavior. D, Acute effects of SR144528, in DBA/2 male and female mice in the two chamber black and white test box, showing time spent in the black and white chamber.
###end p 32
###begin title 33
CB2-R gene targeting by CB2 antisense oligonucleotide modifies behavior
###end title 33
###begin p 34
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi4">[26]</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2-R</italic>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 609 616 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g006">Fig. 6A</xref>
###xml 1160 1167 1152 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g006">Fig. 6B</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10116">rats</span>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:10090">mouse</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 1261 1266 <span type="species:ncbi:10090">mouse</span>
We have previously characterized the effects of peripherally administered cannabinoids in the plus maze test of anxiety using mice and rats [26]. To investigate whether CB2-R gene targeting by CB2-R antisense oligonucleotide (oligo) modifies behavior, we determined whether inhibition of CB2 gene expression in the brain will alter mouse behavior in the elevated plus-maze test. The direct intracerebroventricular (ICV) CB2-R antisense oligo (20 microg in 5 microl) microinjection bilaterally into the mouse lateral ventricles significantly reduced mouse aversions (P<0.05) to the open arms of the plus maze (Fig. 6A). In contrast the performance of mice microinjected with the sense and mismatched oligos were not different from the control mice. Other groups of mice that had been exposed to stress by chronic mild stressors for 4 weeks or by prior prenatal exposure to capsaicin were also tested on the plus-maze after acute treatment with intraperitoneal (ip) injection of JWH015 (20 mg/kg). Stress whether by CMS or prenatal exposure to capsaicin induced gender specific aversions in the plus-maze test which was significantly reduced (p<0.05) by JWH015 (Fig. 6B). These data together with the cerebral microinjection of CB2-R antisense oligo that reduced mouse aversions to the open arms of the plus-maze provides further evidence for the functional presence of CB2-Rs in the brain that influence behavior.
###end p 34
###begin title 35
CB2-R gene targeting modifies behavior.
###end title 35
###begin p 36
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
A, Behavioral effects of CB2 intracerebral gene targeting by antisense oligonucleotide microinjected into the mouse brain and performance of mice in plus-maze test was assessed before and after 3 days of twice daily microinjection. AS1 and AS2 were before and after CB2 antisense oligo microinjection. V1 and V2 are controls. B, performance in plus-maze test following CMS or mice exposed prenatally to capsaicin and the effect of JWH015 (20 mg/kg).
###end p 36
###begin title 37
Effects of CB2-R activation and blockade on anhedonia induced by chronic mild stress (CMS)
###end title 37
###begin p 38
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g007">Fig. 7A</xref>
###xml 748 751 748 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Willner1">[2]</xref>
###xml 1020 1027 1020 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g007">Fig. 7B</xref>
###xml 1482 1489 1482 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g007">Fig. 7C</xref>
###xml 1734 1738 1734 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ishiguro1">[19]</xref>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
###xml 1607 1611 <span type="species:ncbi:10090">mice</span>
###xml 1788 1792 <span type="species:ncbi:10090">mice</span>
###xml 2006 2011 <span type="species:ncbi:9606">human</span>
In separate experiments we investigated the effects of selected CB2-R agonist or antagonists on anhedonia induced by chronic mild stress. There was no difference in the amount of water that both the CMS and control animals drank in the weekly over night water consumption test, indicating that stress did not interfere with water intake of the animals. In contrast after anhedonia was established by the CMS regime, there was significant reduction (P<0.05-P<0.01) in the amount of sucrose solution consumed by the CMS mice in comparison to control animals in the weekly over night sucrose consumption test (Fig. 7A). The establishment of anhedonia (lack of pleasure) is one of the major validated endpoints in the model of depression using rodents [2]. We then investigated the effects of daily treatment with selected doses of the CB2-R agonist JWH015 (20 mg/kg) or the CB2-R antagonist AM630 (1 and 3 mg/kg) in the CMS and control mice. JWH015 induced variable consumption of sucrose solution in CMS and control mice (Fig. 7B). Stressed mice chronically treated with JWH015 did not differ in their consumption of sucrose solution from the CMS animals that were not treated. Curiously however consumption of sucrose solution was enhanced in control mice (p<0.05) treated daily with JWH015 by week 2 and 4. In contrast to the effects of the CB2-R agonist JWH015, the antagonist AM630 did not significantly modify the intake of sucrose solution in the CMS or in the control animals (Fig. 7C). It is to be noted however, that we have previously shown that alcohol intake was dramatically enhanced in stressed mice treated with JWH015 and that the stressed enhanced alcohol consumption was blocked by the CB2-R antagonist AM630 (p>0.05) [19]. Thus on the basis of alcohol consumption in CMS mice, and the augmentation of alcohol consumption by treatment with the CB2-R agonist and blockade of the stressed induce alcohol consumption by treatment with the CB2-R antagonist, along with the Q63R polymorphism in human alcoholics and depressed subjects, we suggest that CB2-Rs plays a role in substance abuse and depression.
###end p 38
###begin title 39
CB2-R- activation and blockade on anhedonia induced by chronic mild stress (CMS).
###end title 39
###begin p 40
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
A, Weekly sucrose consumption in stress and control mice. B, Effect of JWH015 (20 mg/kg) on mouse weekly sucrose consumption test. C, Effect of AM630 (1 and 3 mg/kg) on mouse weekly sucrose consumption test.
###end p 40
###begin title 41
Subcellular localization of CB2-Rs in the rodent brain
###end title 41
###begin p 42
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Beltramo1">[23]</xref>
###xml 316 322 316 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g008">Fig. 8</xref>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g008">Fig. 8A</xref>
###xml 555 562 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001640-g008">Fig. 8B</xref>
We performed an immunoelectron microscopy study to determine the subcellular localization of CB2-R in the selected rodent brain structures that we have shown contain CB2-R immunoreactivity [23]. CB2-R-IR was observed mostly in dendrites near the plasma membrane and close to the area of contact with axon terminals (Fig. 8). Some CB2-R immunoreactive dendrites were seen to receive multiple synaptic contacts from axon terminals lacking CB2-R-IR (Fig. 8A). In some areas, a CB2 immunoreactive dendrite was contacted by a non-immunoreactive axon terminal (Fig. 8B). This pattern of immunostaining on dendrites and cell bodies indicates a post-synaptic localization in the areas that were analyzed (hippocampus and cerebral cortex). Therefore our results further confirm the presence of CB2-Rs in neuronal structures in the central nervous system.
###end p 42
###begin title 43
###xml 28 31 <span type="species:ncbi:10116">rat</span>
Subcellular localization of rat hippocampal CB2-Rs.
###end title 43
###begin p 44
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
A, a CB2-IR dendrite [CB2(+) D] receiving multiple synaptic contacts from axon terminals lacking CB2-R immunolabeling [CB2(-) AT]. B, a CB2-IR dendrite [CB2(+) D] was contacted by a non-immunoreactive axon terminal [CB2(-) AT]. Scale bar represents 0.3 microm.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi2">[18]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi3">[20]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Beltramo1">[23]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-VanSickle1">[21]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Beltramo1">[23]</xref>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 911 914 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1214 1217 1214 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 894 899 <span type="species:ncbi:10090">mouse</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
There is little or no information about the role of CB2-Rs in depression and addictive disorders. Indeed our studies provide the first evidence for a role of CB-Rs in depression and substance abuse. These findings are of importance as it opens new areas of research and approaches in understanding depression and addictive disorders for which pharmacological treatment has been disappointing. Reports by our group [18]-[20], [23], and others [21]-[23], have identified the functional presence of CB2-Rs in neuronal and glial processes contrary to the view that the CB2-Rs were restricted to peripheral tissues and predominantly in immune cells. We also found differential modification of CB2 gene expression in brain regions of animals treated with abused substances like cocaine, morphine and alcohol and in those subjected to stressors, including CMS and pre-natal capsaicin exposure. In the mouse model, the CB2 gene transcripts were present in whole brain preparations following CMS and CB2-R protein was enhanced by CMS and prenatal capsaicin exposure. Chronic treatment with CB2-R agonist JWH015 enhanced alcohol consumption in stressed but not in control mice. In animals that developed alcohol preference, CB2 gene expression was down regulated in the midbrain and striatum suggesting the involvement of CB2-Rs in the effects drugs of abuse.
###end p 46
###begin p 47
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB1</italic>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Zhang1">[27]</xref>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Zhang1">[27]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Karsak1">[28]</xref>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Sipe1">[29]</xref>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Sipe1">[29]</xref>
###xml 647 650 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Karsak1">[28]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Sipe1">[29]</xref>
###xml 805 808 805 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 974 977 974 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1326 1334 1326 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1341 1345 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Sipe1">[29]</xref>
###xml 1366 1369 1366 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1474 1477 1474 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1639 1642 1639 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1691 1695 1691 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ishiguro1">[19]</xref>
###xml 1792 1795 1792 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10116">rats</span>
###xml 607 613 <span type="species:ncbi:9606">humans</span>
CB2 gene structure has been poorly defined and characterized and less well studied for CNS function unlike the CB1 gene [27]. However, many features of the CB2 gene structure, regulation and variation are beginning to emerge with identification of neuronal CB2-Rs in CNS [27], [28]. The human CB2 gene consist of a single translated exon [29], and single untranslated exon and similar CB2 gene structure is in mice but encodes two transcripts using different first exons. Most regions of the CB2 gene are highly conserved, but the human has glutamine and mice and rats have arginine at position 63 [29]. In humans a number of polymorphisms in the CB2 gene including Q63R [28], [29] and H316Y have been linked to osteoporosis and autoimmune disorders. We tested the hypothesis that genetic variants of the CB2 gene might have significant effects and association with depression and alcoholism. This hypothesis is supported by the identification of a missense polymorphism at CB2 cDNA position 188-189, which results in a dinucleotide conversion of AA to GG and predicts a non conservative amino acid substitution of glutamine by arginine at position 63 (Q63R). This tandem polymorphism is important as it has the potential to change function in the mature expressed cannabinoid CB2-R as demonstrated in the immune system by an in vitro assay [29]. The association of CB2 gene variation was probed in Japanese subjects to examine the non-synonymous polymorphism, Q63R, in the CB2 gene for association with depression or alcoholism. There was significant difference in allelic frequency between cases and controls at Q63R polymorphism in the CB2 gene in depression in this study and alcoholism [19]. As many genetic variants play various roles in depression and/or substance abuse, variation in CB2 gene, (Q63R) polymorphism may be a previously unknown risk factor in depression and/or alcoholism at least in the Japanese population. If this can be generalized to other ethnicities, then the results support the possibility of targeting the cannabinoid system using CB2-R ligands in depression and drug abuse and perhaps in their co-morbidity. It is therefore tempting to speculate that the reported effects of alcohol may be associated with changes in the cannabinoid system, with CB2-Rs playing a regulatory role.
###end p 47
###begin p 48
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 408 411 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Valenzano1">[25]</xref>
###xml 1403 1407 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ibrahim1">[13]</xref>
###xml 1409 1413 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Valenzano1">[25]</xref>
###xml 1745 1752 1745 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2112 2116 2112 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Nieri1">[30]</xref>
###xml 2118 2122 2118 2122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ehrhart1">[31]</xref>
###xml 2212 2216 2212 2216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Zhong1">[32]</xref>
###xml 452 457 <span type="species:ncbi:10090">mouse</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 850 855 <span type="species:ncbi:10090">mouse</span>
We then hypothesized that if CB2-Rs are present in the brain, then antisense oligonucleotides complementary to CB2 mRNA transcript will block translation of or stimulate degradation of CB2 mRNA. It is therefore of importance to determine whether inhibition of CB2 gene expression in the brain will alter behavior as observed with the exogenous administration of CB2-R ligands. Direct intracerebroventricular CB2 oligonucleotide microinjection into the mouse brain reduced mouse aversion, further indicating the functional presence of CB2-Rs in the brain that influence behavior. This behavioral evidence for the functional presence of CB2-Rs in brain was further investigated by the exogenous administration of CB2-R agonists and antagonist. The behavioral effects of acute treatment with JWH015, a CB2-R agonist and SR144528, a CB2-R antagonist, in mouse spontaneous locomotor activities, and in the two- compartment black and white box lends further support that CB2-Rs in the brain modifies behavior. Similar observations have been reported for the effects of a CB2-R agonist, GW405833 [25]. Curiously, the observation that CB2-R agonists induces sedation and catalepsy only at higher doses has been interpreted by this group and others in rodent models of pain, to have a potential to treat pain without eliciting the centrally-mediated side effects without the psychoactivity associated with CB1-R [13], [25]. With the recent definitive demonstration of neuronal CB2-Rs in the brain, one possible explanation may be that CB2 and CB1 cannabinoid receptors work independently and/or cooperatively in different neuronal populations to regulate a number of physiological activities influenced by cannabinoids. These effects of CB2-R ligands in in vivo behavioral tests are provided as functional evidence of CB2-R in the brain that plays a role in motor function and emotionality tests. The antagonism of the behavioral effects of CB2-R agonist, JWH015 by SR144528 or AM630 was not determined in this study. However, other studies have demonstrated the selectivity of JWH015 on mediating its effects via CB2-Rs [30], [31] and the effect of JWH015 was completely blocked by the CB2 specific antagonist, SR144528 [32].
###end p 48
###begin p 49
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Beltramo1">[23]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-VanSickle1">[21]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Beltramo1">[23]</xref>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 653 660 653 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 782 785 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 968 972 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-VanSickle1">[21]</xref>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 1334 1338 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 1561 1564 1561 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1613 1617 1613 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Gong1">[24]</xref>
###xml 634 637 <span type="species:ncbi:10116">rat</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 1114 1117 <span type="species:ncbi:10116">rat</span>
Abundant CB2-R immunoreactivity in neuronal and glial processes was detected but at a much lower level than CB1 receptors as reported [23]. This is supported by reports of the presence of CB2-Rs in brain stem, cortex, cerebellum, dorsal root ganglion and spinal cord [21]-[23]. There is still some controversy on the specificity of CB2-R staining because most of the antibodies are capable of producing non-specific staining. Therefore, very rigorous controls have been utilized in our study including 1) the pre-adsorption and co-incubation of the CB2-R antibody with the immunizing peptide resulting in blocking CB2 staining in the rat cerebellum, 2) in situ hybridization data show that CB2 gene is expressed in the cerebellum of wild type and not in the CB2 knockout mice, with CB2 gene being absent in the sense control in the wild type mice. The absence of CB2 mRNA in CB2-R deficient mice and presence in wild type controls has also been demonstrated by others [21]. Moreover, in previous control experiments we had demonstrated that using two types of CB2 antibodies, similar staining patterns in both the rat spleen and cerebellum [24] were reported. Western blot analyses revealed specific bands that were identified using CB2 antibodies and were absent when the CB2 antibodies were pre-adsorbed with the immunizing peptide [24]. Furthermore, the expression levels of the CB1 gene using RT-PCR analysis was 100 times that of the CB2 gene expression levels with reference to the brain stem. We have also confirmed that the spleen has the most abundant CB2 gene transcripts when compared to other regions [24].
###end p 49
###begin p 50
###xml 1013 1017 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Pickel1">[33]</xref>
###xml 1512 1516 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Onaivi2">[18]</xref>
As definitive electron microscopic evidence is needed to precisely determine the subcellular localization of CB2-Rs, our transmission electron micrograph data using immunoelectron microscopy approach shows a high-resolution definition of hippocampal CB2-R localization at the ultrastructural level. Electron micrographs from hippocampal areas show dendrites with immunostaining for CB2-Rs with diffuse black deposits and mitochondria clearly visible. In some areas axon terminals were not immunoreactive for CB2-Rs and small rounded synaptic vesicles were seen. An axon terminal making contact with a dendrite but without immunostaining for CB2-Rs was apparent. The pattern of staining in most hippocampal areas appears to be mainly post-synaptic localization of CB2-Rs. For example at the area of the synaptic contacts seen the synapse appear to be excitatory and possibly glutamatergic. We cannot exclude that some of the CB2-Rs may be presynaptic, just like CB1-Rs are not exclusively presynaptic in the brain [33]. CB1-Rs are known to be mainly presynaptic in the CNS where cannabinoids act at presynaptic CB1-Rs and endocannabinoids have emerged as one of the classes of retrograde messengers involved in the regulation of synaptic transmission. The functional implication of pre- and/or post-synaptic localization of CB2-Rs awaits further electrophysiological investigation and image analysis of this interesting component of the EPCS. The current understanding of CNS CB2-Rs was the subject of our review [18] and future studies will continue to characterize the specificity of CB2-R mediated behavioral effects and their physiological roles. Thus, our data demonstrate the functional expression of CB2-Rs in brain that may provide novel targets for the effects of cannabinoids in depression and substance abuse disorders beyond neuro-immunocannabinoid activity.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 52
###begin p 53
###xml 4 12 <span type="species:ncbi:9606">patients</span>
166 patients with Major depression (excluded bipolar disorders) diagnosed as depressed by DSM-IIIR criteria without other psychiatric diagnoses, recruited under informed consent. 487 age- and gender-matched controls were research volunteers. They were recruited from north-mid main island area in Japan and provided written informed consent. The genetics study using the DNA of subjects, who provided written consent, was approved by ethics committee of University of Tsukuba.
###end p 53
###begin title 54
Animal subjects
###end title 54
###begin p 55
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Buckley1">[34]</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10116">rats</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Three strains (DBA/2, C57BL/6 and BALBc), male and female mice and Sprague Dawley rats were used. CB2 knockout mice (CB2-/-) and their wild type littermates used in this study CB2-/- was developed by Buckley et al, 2000, [34] and obtained from the National Institutes of Health through Dr. Kunos of NIAAA-NIH, USA. Animals were housed according to National Institutes of Health and institutional guidelines for laboratory animals. All procedures were approved by the local Animal Care and Use Committees in all the institutions involved with the project.
###end p 55
###begin title 56
Drugs
###end title 56
###begin p 57
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
JWH015 (a putative CB2 agonist) and AM60, a CB2-R antagonist were obtained from Sigma-Aldrich (MO, USA) and Cayman Chemicals (MI, USA) while SR144528 (a CB2 antagonist) was donated by Sanofi, (France). Primary CB2 antibodies and their blocking peptide were obtained from Santa Cruz (Ca, USA). For the in vivo experiments, JWH015, AM630 and SR144528 were made up in ethanol: emulphur: water in a ratio of 1:1:18.
###end p 57
###begin title 58
Behavioral Analyses
###end title 58
###begin p 59
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
BALB/c male and female mice were housed 12 hrs in light and 12 hrs in dark. Experimental mice (N = 10 per group) were exposed to CMS everyday for four weeks to achieve anhedonia (CMS test). These experimental animals were subjected to the weekly CMS regime consisting of three 10 hr periods of 45degrees cage tilt; 3 periods of overnight stroboscopic illumination, two 10 hr periods of empty water bottle; two periods of overnight food or water deprivation; two 10 hr periods of damp bedding. The CMS treated and non-stressed groups consisted of 30 mice each and were split into three subgroups, respectively. All non-stressed groups were given food and water at all times, as well as comfortable cage surroundings, while the experimental group was housed in a different room. In the first set of studies animals in both the stress and control groups of 10 animals per group were treated daily with the CB2 agonist JWH015 (20 mg/kg) and the control groups with the vehicle for 4 weeks. In the second round of CMS study animals in both the stress and control groups of 10 animals per group were treated daily with the CB2 antagonist AM630 ( 1 and 3 mg/kg) and the control groups with the vehicle for 4 weeks. Once every week sucrose consumption was measured as a test of anhedonia. At the end of the stress regime, locomotor activities stereotype behavior was measured in activity monitors in all groups.
###end p 59
###begin p 60
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
The acute effects of JWH015, a CB2-R agonist and SR144528 a CB2-R antagonist on mouse locomotor activity and stereotypy using activity monitors and in the two- compartment black and white box were assessed. The pretreatment times were 10 min- for the agonist and 30 min for the antagonist. Animals were placed in activity monitors or in the two- compartment black and white box. Spontaneous locomotor activities and stereotype behavior in the activity monitors and time spent and locomotor activities in the box were obtained from the automated system. The doses of the agonist and antagonist were 1-20 mg/kg except as indicated in specific experiments as described for the CMS experiments. The performance of mice in the plus-maze test of anxiety following intracerebroventricular (ICV) administration of CB2 antisense oligonucleotide (oligos) (20 microg in 5 microl) was assessed before and after 3 days of twice daily microinjection and compared to mice injected with sense and mismatched oligos.
###end p 60
###begin title 61
Western Blotting
###end title 61
###begin p 62
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:9925">goat</span>
###xml 372 378 <span type="species:ncbi:9986">rabbit</span>
Equal amount of protein 20 microg obtained from the brains of stressed and control mice were loaded and separated by 10% SDS-PAGE and then transferred onto nitrocellulose membrane. The nitrocellulose was washed and blocked in PBS containing 2% non-fat milk and incubated with the CB2 antibody overnight. The membranes were washed and incubated with a conjugated goat anti-rabbit secondary antibody and processed for immunoreactivities with and without pre-incubation of the primary antibodies with CB2 peptide.
###end p 62
###begin title 63
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
CB2 gene expression and regulation by drug and alcohol treatment
###end title 63
###begin p 64
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1101 1104 1101 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">Mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
CB2-R gene expression was determined in whole mouse brains subjected to stressors and those treated chronically with heroin (10 mg/kg) and cocaine (40 mg/kg) and then precisely in brain regions of naive mice and those exposed acutely or chronically to escalating doses of alcohol. CB2 gene expression was then determined in animals that developed or did not develop alcohol preference. Mice were sacrificed and whole brains were taken or dissected out for extraction of RNA. Control group of mice (n = 6) did not have access to ethanol but only to water in that experiment, and RNA was also extracted in a same way for comparison to the mice that developed ethanol preference. Where indicated brains were dissected into striatum, hippocampus and midbrain. RNA was extracted using RNeasy kit (QIAGEN, K.K., Tokyo, Japan) and cDNA was synthesized by Revertra Ace (TOYOBO, Japan) and oligo dT primer. The expression of CB2 gene was compared by TaqMan real-time PCR with an ABI PRISM 7900 HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA), using the TaqMan gene expression assay for CB2 (Mm0043826_m1).
###end p 64
###begin title 65
Association study between the Q63R polymorphism and depression
###end title 65
###begin p 66
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Ishiguro1">[19]</xref>
CB2 gene has two non-synonymous polymorphisms, Q63R and H316Y according to public database NCBI (). However, analysis of secondary structure of CB2 gene with Chou-Fasman, Robson and hydrophilic/ hydrophobic structure extimation methods using computer program GENETYX (Genetyx corporation, Tokyo, Japan) revealed a potential structural change in CB2 gene only by the Q63R but not by the H316Y polymorphism of the gene. Therefore, we focused on the Q63R polymorphism and the genotype was determined by restricted fragment length polymorphism (RFLP) method as described in our previous report [19].
###end p 66
###begin title 67
Real Time-PCR
###end title 67
###begin p 68
###xml 700 703 691 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
Total RNA was extracted from brain tissues using RNAzol B (Tel-Test, Friendswood, TX). Single strand cDNA was synthesized from total RNA using SuperScripttrade mark first-strand synthesis system for RT-PCR (GIBCO/BRL, Rockville, MD). For quantitative real time PCR assays, the exon-specific primers and fluorescent Fam-labeled probes across different exon regions were designed using Primer Express program (Applied Biosystems, Foster City, CA). Beta-actin Fam-labeled probe was used for normalization. Two-step PCR program was used as the default of ABI 7900 HT PCR instrument (Applied Biosystems, Foster City, CA). In the assay, we used spleen as positive control because of its high expression of CB2 gene and no cDNA in the TaqMan PCR reaction as negative control. The control brain samples were set at 1.0 with glyceraldehydes-3-phosphate dehydrogenase (GAPDH) pre-developed TaqMan assay reagent as endogenous control (FAMtrade mark Dye/MGB probe). Calculation of real time PCR was carried out according to User Bulletin #2 for ABI Prism 7700 Sequence Detection System.
###end p 68
###begin title 69
Immunohistochemistry and electron microscopy
###end title 69
###begin p 70
###xml 1398 1399 1366 1367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1400 1401 1368 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1635 1639 1603 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Paxinos1">[35]</xref>
###xml 2871 2875 2829 2833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Reynolds1">[36]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 41 45 <span type="species:ncbi:10116">rats</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10116">rats</span>
###xml 786 790 <span type="species:ncbi:9925">goat</span>
###xml 1064 1068 <span type="species:ncbi:9925">goat</span>
###xml 1074 1080 <span type="species:ncbi:9986">rabbit</span>
###xml 1764 1768 <span type="species:ncbi:10090">mice</span>
###xml 1837 1841 <span type="species:ncbi:10116">rats</span>
Mice and male Sprague Dawley (180-200 g) rats were anesthetized with choral hydrate (300 mg/kg) pentobarbital, perfused transcardially with saline and then with 100 ml of 4% paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4) for mice and 500 ml of the same fixative solution for rats. Brains were dissected, postfixed in the same fixative solution for 2 hours at room temperature, equilibrated with 30% sucrose in PB at 4degreesC, frozen and cut into saggital 20-40 microm sections using a cryostat. Sections were processed for immunohistochemistry as follows. Floating sections were incubated with 1% hydrogen peroxide in phosphate-buffered saline (PBS) for 10 min at room temperature to inhibit endogenous peroxidase, washed three times with PBS, incubated for 1 h in 3% normal goat serum (NGS) in Tris-buffered saline (TBS), pH 7.4 at 22degreesC, incubated in primary CB2 antibody obtained from (Santa Cruz, Ca, USA), diluted 1: 300 in TBS containing 3% NGS for 24 h at 4degreesC, rinsed, incubated for 1 h at 22degreesC in 1:200 dilution of biotinylated goat anti-rabbit secondary antibody (Vector, Burlingame, CA, USA) for 1 h, rinsed, incubated with avidin-biotin peroxidase complex (ABC) reagent for 1 h (Vector), rinsed, and then incubated in a solution containing 22 microg/ml diaminobenzidine (DAB) (Electron Microscopy Sciences, Fort Washington, PA) and 0.003% hydrogen peroxide (H2O2) for color deposition. Sections were mounted on coated slides, dehydrated, cover slipped, viewed and photographed using Zeiss and Leitz microscope and a Nikon digital camera, immunoreactive elements plotted onto the atlas depictions [35], and images edited using photoshop (vCS; Adobe systems). As additional control, iCB2 of brain sections from CB2-R deficient mice and wild type controls were also analyzed. For electron microscopy, rats were perfused with 500 ml of 4% paraformaldehyde, 0.1% purified glutaraldehyde fixative in PB, brains were removed, postfixed in the same fixative solution for two hours and saggital sections (50 microm) were obtained using a vibrotome. Then, sections were processed for inmmunohistochemistry following the same immunoperoxidase protocol. After that, sections were fixed with 1% osmium tetroxide in 0.1 M PB for 1 h, dehydrated through a series of graded alcohols (including 60 min in 70% alcohol containing 1% uranyl acetate), and then with propylene oxide. Afterwards, they were flat-embedded in Durcupan ACM epoxy resin (Electron Microscopy Sciences, Fort Washington, PA). Embedded sections were polymerized at 60degreesC for 2 days. Ultrathin sections of 70 nm were cut from the outer surface of the tissue with an ultramicrotome (Leica, Microsystems, Wetzlar, Germany) using a diamond knife (Diatome, fort Washington, PA). The sections were collected onto 300 mesh cooper grids and counterstained with Reynolds lead citrate [36]. Sections were examined and photographed using a Zeiss 109 transmission electron microscope and 35 mm Kodak technical Pan professional 2415 films.
###end p 70
###begin title 71
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ hybridization and probes
###end title 71
###begin p 72
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 1082 1083 1034 1035 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 1000 1005 <span type="species:ncbi:10090">mouse</span>
###xml 1852 1857 <span type="species:ncbi:4932">yeast</span>
Biotin labeled RNA probes were used for in situ hybridization. The full length of human CB2 gene was subcloned from pcDNA3.1/CB2 (UMR cDNA resource center, Rolla, MO) into pBluescript II at the restriction sites of EcoR I and Xho I. The pcBluescript II/CB2 was linearized with Xho I (Anti-sense probe) or Eco RI (sense probe). The CB2 riboprobes were synthesized by incubating for 60 min at 37degreesC. 1 microg linearized plasmid in 2 microl 10X transcription buffer, 1 microl RNase inhibitor, 2 microl Biotin RNA labeling Mix containing 1 mM ATP/GTP/CTP, 650 microM UTP, 350 microM biotin-UTP (Roche Applied Science, Germany), 40 U T7 (anti-sense probe), or T3 RNA polymerase (sense probe) in a final volume of 20 microl. The reaction mixture was subsequently incubated for 15 min at 37degreesC with 1 U RNase-free DNase I. The riboprobes were precipitated using LiCl and ethanol. The CB2 probes were diluted in 100 microl TE. Coronal cerebellum sections (20 microm) of wild type and CB2 knock-out mouse were cut in a cryostat microtome. All solutions were prepared in deionized H2O treated with 0.1% (V/V) diethylpyrocarbonate and autoclaved. Sections were incubated with 1% hydrogen peroxide in phosphate buffered saline (PBS) for 10 minutes at room temperature to inhibit endogenous peroxidase, washed three times with PBS. Sections were fixed by immersion in 4% paraformaldehyde in PBS, pH 7.4, and then briefly rinsed twice with PBS. After treatment with Proteinase K, sections were refixed in 4% paraformaldehyde. The sections then were acetylated by immersion in 0.1 M triethanolamine containing 0.25% acetic anhydride, permeabilized by 1% Triton X-100, and rinsed twice with PBS. Prehybridization was carried out at 4degreesC overnight with prehybridization solution (50% formamide, 4xSSC, 0.5x Denhardt's solution, 100 mM DTT, 250 microg/ml yeast tRNA, and 250 microg/ml salmon sperm DNA). For hybridization, the sections were incubated in a prehybridization solution containing 1 microg/ml of cRNA probe, incubated at room temperature overnight on a shaker. Sections were immersed sequentially in 0.2x SSC twice and buffer 1(0.1 M tris pH 7.5, 0.15 M NaCl) twice. The sections were incubated with ABC reagent for 1 hour (Vector), rinsed, and then incubated with diaminobenzidine for color deposition.
###end p 72
###begin title 73
Statistical analysis
###end title 73
###begin p 74
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CB2</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 128 134 <span type="species:ncbi:9103">Turkey</span>
Data for motor function tests and emotionality tests were analyzed by analysis of variance for multiple comparisons followed by Turkey's test where appropriate. The accepted level of significance is p<0.05. For CB2 gene expression analysis, unpaired t test (GraphPad software) was used and p<0.05 is the accepted level of significant difference. Deviations of the observed allele and genotype distributions from Hardy-Weinberg equilibrium (HWE), were calculated by HWE computer program, and differences in allele frequencies between case-control groups were tested for significance using Fisher's exact tests on 2x2 contingency tables.
###end p 74
###begin p 75
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001640-Buckley1">[34]</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
The CB2 knockout and their wild-type control mice were developed by Buckley et al., 2000 [34], and obtained from NIAAA through Dr. Kunos.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
###xml 22 29 <span type="species:ncbi:4097">tobacco</span>
Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis.
###end article-title 77
###begin article-title 78
Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS.
###end article-title 78
###begin article-title 79
Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.
###end article-title 79
###begin article-title 80
Role of endocannabinoid system in mental diseases.
###end article-title 80
###begin article-title 81
Role of the endocannabinoid system in depression and suicide.
###end article-title 81
###begin article-title 82
Cannabis abuse as a risk factor for depressive symptoms.
###end article-title 82
###begin article-title 83
###xml 40 46 <span type="species:ncbi:9606">people</span>
Cannabis use and mental health in young people: cohort study.
###end article-title 83
###begin article-title 84
###xml 40 49 <span type="species:ncbi:3483">marijuana</span>
Endocannabinoids : the brain and body's marijuana and beyond.
###end article-title 84
###begin article-title 85
Molecular characterization of a peripheral receptor for cannabinoids.
###end article-title 85
###begin article-title 86
###xml 62 67 <span type="species:ncbi:9606">human</span>
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
###end article-title 86
###begin article-title 87
###xml 136 139 <span type="species:ncbi:10116">rat</span>
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
###end article-title 87
###begin article-title 88
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
###end article-title 88
###begin article-title 89
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
###end article-title 90
###begin article-title 91
###xml 80 85 <span type="species:ncbi:9606">human</span>
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study.
###end article-title 91
###begin article-title 92
###xml 84 113 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.
###end article-title 92
###begin article-title 93
###xml 103 108 <span type="species:ncbi:9606">human</span>
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.
###end article-title 93
###begin article-title 94
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
###end article-title 94
###begin article-title 95
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans.
###end article-title 95
###begin article-title 96
Methods to study the behavioral effects and expression of CB2 cannabinoid receptor and its gene transcripts in the chronic mild stress model of depression.
###end article-title 96
###begin article-title 97
Identification and functional characterization of brainstem cannabinoid CB2 receptors.
###end article-title 97
###begin article-title 98
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.
###end article-title 98
###begin article-title 99
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.
###end article-title 99
###begin article-title 100
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
###end article-title 100
###begin article-title 101
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
###end article-title 101
###begin article-title 102
Pharmacological characterization of cannabinoids in the elevated plus maze.
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.
###end article-title 103
###begin article-title 104
###xml 52 57 <span type="species:ncbi:9606">human</span>
Cannabinoid receptor type 2 gene is associated with human osteoporosis.
###end article-title 104
###begin article-title 105
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.
###end article-title 105
###begin article-title 106
###xml 88 91 <span type="species:ncbi:10116">rat</span>
CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.
###end article-title 106
###begin article-title 107
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation.
###end article-title 107
###begin article-title 108
CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
###end article-title 108
###begin article-title 109
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.
###end article-title 109
###begin article-title 110
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
###end article-title 110
###begin article-title 111
###xml 4 7 <span type="species:ncbi:10116">rat</span>
The rat brain in stereotaxic coordinates.
###end article-title 111
###begin article-title 112
The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by NIDA/IRP and ESO acknowledges financial support from William Paterson University center for research and the Dean, Dr. DeYoung, student worker fund. HI and TA acknowledge Public interest trust, Research aid fund for stress related diseases with commemoration of Imaikimi. The sponsors or funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.
###end p 114

